About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Progyny, Inc. - Common Stock (NQ:PGNY)

27.76 -0.09 (-0.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2
Let’s dig into the relative performance of Progyny (NASDAQ:PGNY) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
1 Russell 2000 Stock to Consider Right Now and 2 That Underwhelm
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
Progyny (NASDAQ:PGNY): An Affordable Growth Stock With Strong Earnings and Reasonable Valuation ↗
Via Chartmill
News headline image
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
Progyny (NASDAQ:PGNY): A Decent Value Stock Combining Reasonable Valuation and Solid Fundamentals ↗
Via Chartmill
Progyny (NASDAQ:PGNY) Shares Slide After Q2 Beat Overshadowed by Weak Guidance ↗
Via Chartmill
Progyny (NASDAQ:PGNY): An Affordable Growth Play With Double-Digit Earnings Expansion ↗
Via Chartmill
News headline image
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook ↗
Progyny (NASDAQ:PGNY) CEO Pete Anevski said the company expects member engagement and utilization to rebound following a more pronounced summer seasonal slowdown, while early renewal and new-client... 
Via MarketBeat
News headline image
Progyny (PGNY) Q2 2026 Earnings Call Transcript ↗
Record revenue and gross profit as client count climbs to 604 and member base expands. 
Via The Motley Fool
Topics Earnings
News headline image
The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call
Progyny’s second quarter results were met with a negative market reaction, despite the company delivering revenue and non-GAAP profit above Wall Street expec... 
Via StockStory
Topics Earnings
Progyny (PGNY): Strong Growth with Technical Setup Quality ↗
Via Chartmill
Progyny Inc (NASDAQ:PGNY) Offers Affordable Growth With Strong Fundamentals ↗
Via Chartmill
Progyny Inc (NASDAQ:PGNY) Screens Well on Caviar Cruise Quality Investing Metrics ↗
Via Chartmill
News headline image
2 Cash-Heavy Stocks on Our Watchlist and 1 We Avoid
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o... 
Via StockStory
News headline image
Why Progyny (PGNY) Shares Are Sliding Today
What Happened? Shares of fertility benefits company Progyny (NASDAQ:PGNY) fell 4.5% in the afternoon session after the company issued a weak forecast, oversh... 
Via StockStory
News headline image
Why Progyny Stock Plunged, Then Gradually Recovered Today ↗
Progyny stock initially plummeted this morning but has steadily marched back toward even. 
Via The Motley Fool
News headline image
Progyny Q2 Earnings Call Highlights ↗
Progyny (NASDAQ:PGNY) reported record quarterly revenue, gross profit and adjusted EBITDA for the second quarter of 2026, while management said early sales commitments and client-retention activity... 
Via MarketBeat
Topics Earnings
News headline image
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 5.3% year on year to $3... 
Via StockStory
News headline image
Progyny’s (NASDAQ:PGNY) Q2 CY2026: Beats On Revenue But Stock Drops 10.2%
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 5.3% year on year to $35... 
Via StockStory
News headline image
What To Expect From Progyny’s (PGNY) Q2 Earnings
Fertility benefits company Progyny (NASDAQ:PGNY) will be announcing earnings results tomorrow after market close. Here’s what investors should know. Progyny ... 
Via StockStory
News headline image
Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors ↗
Disposition reduced her direct holdings by 5% through a combination of Rule 10b5-1 plan sales and tax-withholding shares, leaving her with a $2.26 million stake. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 Facing Challenges
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's
Check out the companies making headlines yesterday: RXO (NYSE:RXO): Freight Delivery Company RXO (NYSE:RXO) rose by 4.2% on Monday after Stifel raised its pr... 
Via StockStory
News headline image
3 Small-Cap Stocks with Warning Signs
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
Topics Electric Vehicles
News headline image
Progyny (PGNY) Stock Is Up, What You Need To Know
What Happened? Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.5% in the afternoon session after KeyBanc raised its price target on the s... 
Via StockStory
News headline image
Progyny (PGNY): Buy, Sell, or Hold Post Q1 Earnings?
Progyny trades at $31.10 per share and has stayed right on track with the overall market, gaining 13.4% over the last six months. At the same time, the S&P 5... 
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Value Stocks That Fall Short
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
What Does the Sale of Progyny Shares by the CFO Mean for Investors? ↗
Progyny delivers fertility benefits to employers nationwide; a key insider recently trimmed their stake, according to SEC filings. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Russell 2000 Stock for Long-Term Investors and 2 We Turn Down
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.